Cytel HEOR & RWE

For over thirty years, Cytel has been the industry leader in delivering advanced data analytics solutions to top biotech and pharmaceutical companies. In 2020, Cytel joined forces with specialist consultancies, Ingress Health and Purple Squirrel Economics, to create a global team of experts providing industry-leading capabilities in health economics and outcomes research (HEOR) and real-world evidence (RWE). Together our mission is to help you unlock the full promise of your data. At Cytel, were designed for results

Health economic modelling,real-world evidence,network meta-analyses,observational studies,claims data analyses,systematic literature reviews,survival analysis,patient reported outcomes,hta,end point validation,bayesian methodologies,patient preference studies,cure models,adherence and persistence studies,maic & stc,hrqol studies,core and early modelling,budget impact modelling,global value dossier,and linked pro- & retrospective database studies

Cytel heor & rwe operates in the Pharmaceutical manufacturing industry.

Cytel heor & rwe's revenue is 11m - 100m

Cytel heor & rwe has 11 - 50 employees.